Home India news Difficult To Predict If India Will See Second Wave Of COVID-19: ICMR...

Difficult To Predict If India Will See Second Wave Of COVID-19: ICMR Chief

ICMR arrange three new state-of-the-art testing amenities in Noida, Mumbai and Kolkata

New Delhi:

ICMR chief Dr Balram Bhargava mentioned has mentioned that it’s tough to foretell whether or not or not India will see a second wave of COVID-19 infections and there will probably be smaller peaks at totally different occasions as a result of various geography of the nation.

In an unique interview with ANI, (Prof) Dr Bhargava additionally mentioned that the scenario was quickly evolving and there have been immense variations in unfold of an infection and mortality charges in numerous geographies and throughout totally different demographics world wide.

“SARS-CoV-2 is a novel virus. There is still a lot we don’t know about it. We have also seen immense variations in the spread of infection and mortality rates in different geographies and across different demographics around the world. So, it is difficult to predict whether or not India will see a second wave of infections. There is also a wide variation in disease distribution in specific states – so one size cannot fit all,” he mentioned.

The Director-General of India Council of Medical Research (ICMR) mentioned other than the scientific inputs, full participation of all residents is important to beat the COVID-19 problem.

“Due to the varied geography of our nation, there would be smaller peaks at different times. The situation is rapidly evolving, and we will continue to monitor it. However, it is pertinent that people follow preventive measures like social distancing, use of masks and hand hygiene. The right intervention approach, the scientific input and full participation of all citizens and communities is essential to overcome the COVID-19 challenge” he mentioned.

Dr Bhargava, a key scientist concerned in monitoring the COVID-19 scenario within the nation, mentioned ICMR has been monitoring this illness since January 2020 and its lab on the National Institute of Virology can be amongst the primary few on the earth to utterly isolate the virus to study extra about its traits and lay the groundwork for locating a possible treatment.

Asked how ICMR will sort out any future risk of virus, Dr Bhargava mentioned that even earlier than COVID-19 struck, ICMR had arrange a platform with different 10 South East Asian nations to conduct collaborative analysis on rising ailments.

“We have been at the forefront of tackling diseases like Nipah, Zika and other emerging infections,” he mentioned.

The scientist mentioned that “three Ds – Data, Development and Delivery” are on the core of tackling any public well being disaster.

“Data is important to make evidence-based decisions for interventions and in policymaking. Development of innovative tools that can drive innovation in the public health space is also critical. For instance, the indigenously developed, rapid and highly accurate ELISA test is helping the country to detect the extent of coronavirus spread in the country. Finally, delivery needs to be strengthened to ensure that these interventions reach the beneficiary,” he mentioned.

Dr Bhargava mentioned ICMR has been regularly ramping up testing capability for the reason that starting of the pandemic.

“We started with less than 100 tests per day near the beginning of the pandemic and today we have the capacity of testing over 5 lakh samples a day with labs set up even at 18,000 feet in Ladakh. ICMR has crossed the milestone of 2,02,02,858 tests and we are now the country with 4th highest number of tests conducted globally,” he mentioned.

ICMR has additionally written to non-public and authorities medical faculties to extend testing for the virus and it’ll help these establishments to get the required infrastructure and coaching for testing, he mentioned.

ICMR just lately arrange three new state-of-the-art testing amenities in Noida, Mumbai and Kolkata, which might improve testing capability, cut back danger of publicity for lab technicians and reduce turn-around time.

“Over time, once the pandemic is controlled, these facilities can also be used for the testing of other diseases such as tuberculosis, Hepatitis B and C, HIV etc,” Dr Bhargava mentioned.

(Except for the headline, this story has not been edited by NDTV employees and is revealed from a syndicated feed.)


Please enter your comment!
Please enter your name here